Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
We’ve recently welcomed Jesse Ahrendt, our new Senior Vice President of Quality Assurance and Regulatory Affairs, who will lead our...
Introducing Jesse Ahrendt, Antheia’s SVP of Quality Assurance & Regulatory Affairs
Synthetic Biology vs Synthetic Chemistry: A Primer
Antheia's 2022 in Review: A Year of Value
In the News: Drug Discovery and Development 2023 Predictions
Antheia CEO on How Biomanufacturing can De-Risk Pharmaceutical Production
In the News: Contract Pharma, Leveraging Fermentation to Produce Complex APIs
Antheia CEO Presents at CPHI on Transforming Pharma Supply Chains [Watch]
Demystifying Synthetic Biology Part V: The Product is Key in Downstream Processing
Introducing Guerin Kob, Antheia’s VP of Supply Chain
Demystifying Synthetic Biology IV: Fermentation Bioprocess Development
Antheia Announces New Financing and Plans to Construct Pilot Plant Facility for Biomanufacturing
Demystifying Synthetic Biology III: The 21st Century Technologies Advancing Synthetic Biology
Introducing CPO Heidi Pucel
In the News: Antheia Senior Scientist Involved in Cancer Research Discovery
Demystifying Synthetic Biology II: Molecular Biology Advancements Enabling Synthetic Biology
Antheia Appoints Heidi Pucel as Chief People Officer
Demystifying Synthetic Biology: Building with the power of biology
Inspirational Women in STEM and Tech: Dr. Christina Smolke of Antheia On The 5 Leadership Lessons...
Seven Biopharma Trends to Watch in 2022
In the News: Seven Biopharma Trends to Watch in 2022